Previous Close | 4.5650 |
Open | 4.7030 |
Bid | 4.6800 x 168000 |
Ask | 4.7490 x 164000 |
Day's Range | 4.7030 - 4.8440 |
52 Week Range | 4.4470 - 8.2140 |
Volume | |
Avg. Volume | 92 |
Market Cap | 1.04B |
Beta (5Y Monthly) | 1.92 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for BO1.F
In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]
Each of these hidden penny stock gems have the potential to provide triple digit growth to investors. Investors are forever on the lookout for Investments that can turn $1 into $2 or more. That is precisely the potential that the stocks below offer to investors. The firms discussed below are also relatively unknown and are generally not household names. They can therefore be characterized as hidden gems given their strong potential upside. As always, invest in penny stocks what you are willing t
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript February 26, 2024 BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.28 EPS, expectations were $-0.24. BioCryst Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]